Clinical Trial Update: EFFICACY of INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION on the POSTOPERATIVE BLOOD LOSS in PATIENTS UNDERGOING RARP for the TREATMENT of PROSTATE CANCER [NA]

View source ↗

Summary

Clinical trial evaluating intraoperative Arista polysaccharide to reduce postoperative blood loss in robotic-assisted radical prostatectomy for prostate cancer.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Arista (oxidized regenerated cellulose)

Snippet

Sponsor: St. Antonius Hospital Gronau | Conditions: Prostate Cancer (Adenocarcinoma), Blood Loss, Postoperative | NA | Status: RECRUITING